Primary cutaneous mucinous carcinoma: Presence of myoepithelial cells as a clue to the cutaneous origin

Hina S. Qureshi, Mohamed Salama, Dhannanjay Chitale, Ila Bansal, Chan K. Ma, Usha Raju, Adrian Ormsby, Min W. Lee

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: Primary cutaneous mucinous carcinoma (PCMC) is a rare malignancy with probable apocrine differentiation. It is important to differentiate it from metastatic mucinous carcinoma (MMC), especially from the breast. The histologic and immunohistochemical features overlap between PCMC and breast mucinous carcinomas. In this study, we introduce the presence of myoepithelial component in PCMC as a new morphologic parameter to distinguish it from MMC from either breast or sites elsewhere in the body. Materials and Methods: We studied 7 cases of PCMC. The possible in situ component in the tumor was assessed by the presence of a peripheral myoepithelial cell layer. Myoepithelial cell differentiation was confirmed with immunohistochemical stains for p63, CK 5/6, calponin, smooth muscle actin (SMA), HHF-35, and CD10. Estrogen and progesterone receptor (ER/PR), gross cystic disease fluid protein (GCDFP 15), CK7, CK20, and S-100 immunostains were also performed. Results: Histologically, multiple small monomorphic epithelial islands floating in multilocular pools of mucin characterized the tumor. Focally, epithelial islands were bordered by dermal connective tissue at the periphery of mucin pools. Secretory snouts were apparent in all cases providing evidence for apocrine differentiation. In 5 of the 7 cases, an in situ component was identified as epithelial islands being bounded by a myoepithelial layer, which was highlighted by p63, CK 5/6, calponin, SMA, and HHF-35. ER/PR and CK7 were positive in all the cases. GCDFP-15 and CD10 were focally positive in the tumor cells and myoepithelial cells, respectively. All 7 cases were negative for S-100 and CK 20. Conclusion: We conclude that an in situ component is frequently present in PCMC (5/7) and may help in distinguishing this entity from MMC, especially of breast origin. Furthermore, it may provide insight into the pathogenetic mechanism of mucinous carcinoma evolving from in situ carcinoma with luminal mucinous distention to cellular tumor with a little surrounding mucin.

Original languageEnglish (US)
Pages (from-to)353-358
Number of pages6
JournalAmerican Journal of Dermatopathology
Volume26
Issue number5
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

Fingerprint

Mucinous Adenocarcinoma
Skin
Mucins
Islands
Breast
Progesterone Receptors
Estrogen Receptors
Smooth Muscle
Actins
Neoplasms
Myoepithelioma
Carcinoma in Situ
Connective Tissue
Cell Differentiation
Coloring Agents
Breast Neoplasms
Carcinoma

Keywords

  • Breast
  • Metastatic carcinoma
  • Mucinous carcinoma
  • Myoepithelium
  • Skin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology

Cite this

Primary cutaneous mucinous carcinoma : Presence of myoepithelial cells as a clue to the cutaneous origin. / Qureshi, Hina S.; Salama, Mohamed; Chitale, Dhannanjay; Bansal, Ila; Ma, Chan K.; Raju, Usha; Ormsby, Adrian; Lee, Min W.

In: American Journal of Dermatopathology, Vol. 26, No. 5, 01.10.2004, p. 353-358.

Research output: Contribution to journalArticle

Qureshi, Hina S. ; Salama, Mohamed ; Chitale, Dhannanjay ; Bansal, Ila ; Ma, Chan K. ; Raju, Usha ; Ormsby, Adrian ; Lee, Min W. / Primary cutaneous mucinous carcinoma : Presence of myoepithelial cells as a clue to the cutaneous origin. In: American Journal of Dermatopathology. 2004 ; Vol. 26, No. 5. pp. 353-358.
@article{201919c6d1154f12ba7c8f2788a863d1,
title = "Primary cutaneous mucinous carcinoma: Presence of myoepithelial cells as a clue to the cutaneous origin",
abstract = "Background: Primary cutaneous mucinous carcinoma (PCMC) is a rare malignancy with probable apocrine differentiation. It is important to differentiate it from metastatic mucinous carcinoma (MMC), especially from the breast. The histologic and immunohistochemical features overlap between PCMC and breast mucinous carcinomas. In this study, we introduce the presence of myoepithelial component in PCMC as a new morphologic parameter to distinguish it from MMC from either breast or sites elsewhere in the body. Materials and Methods: We studied 7 cases of PCMC. The possible in situ component in the tumor was assessed by the presence of a peripheral myoepithelial cell layer. Myoepithelial cell differentiation was confirmed with immunohistochemical stains for p63, CK 5/6, calponin, smooth muscle actin (SMA), HHF-35, and CD10. Estrogen and progesterone receptor (ER/PR), gross cystic disease fluid protein (GCDFP 15), CK7, CK20, and S-100 immunostains were also performed. Results: Histologically, multiple small monomorphic epithelial islands floating in multilocular pools of mucin characterized the tumor. Focally, epithelial islands were bordered by dermal connective tissue at the periphery of mucin pools. Secretory snouts were apparent in all cases providing evidence for apocrine differentiation. In 5 of the 7 cases, an in situ component was identified as epithelial islands being bounded by a myoepithelial layer, which was highlighted by p63, CK 5/6, calponin, SMA, and HHF-35. ER/PR and CK7 were positive in all the cases. GCDFP-15 and CD10 were focally positive in the tumor cells and myoepithelial cells, respectively. All 7 cases were negative for S-100 and CK 20. Conclusion: We conclude that an in situ component is frequently present in PCMC (5/7) and may help in distinguishing this entity from MMC, especially of breast origin. Furthermore, it may provide insight into the pathogenetic mechanism of mucinous carcinoma evolving from in situ carcinoma with luminal mucinous distention to cellular tumor with a little surrounding mucin.",
keywords = "Breast, Metastatic carcinoma, Mucinous carcinoma, Myoepithelium, Skin",
author = "Qureshi, {Hina S.} and Mohamed Salama and Dhannanjay Chitale and Ila Bansal and Ma, {Chan K.} and Usha Raju and Adrian Ormsby and Lee, {Min W.}",
year = "2004",
month = "10",
day = "1",
doi = "10.1097/00000372-200410000-00001",
language = "English (US)",
volume = "26",
pages = "353--358",
journal = "American Journal of Dermatopathology",
issn = "0193-1091",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Primary cutaneous mucinous carcinoma

T2 - Presence of myoepithelial cells as a clue to the cutaneous origin

AU - Qureshi, Hina S.

AU - Salama, Mohamed

AU - Chitale, Dhannanjay

AU - Bansal, Ila

AU - Ma, Chan K.

AU - Raju, Usha

AU - Ormsby, Adrian

AU - Lee, Min W.

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Background: Primary cutaneous mucinous carcinoma (PCMC) is a rare malignancy with probable apocrine differentiation. It is important to differentiate it from metastatic mucinous carcinoma (MMC), especially from the breast. The histologic and immunohistochemical features overlap between PCMC and breast mucinous carcinomas. In this study, we introduce the presence of myoepithelial component in PCMC as a new morphologic parameter to distinguish it from MMC from either breast or sites elsewhere in the body. Materials and Methods: We studied 7 cases of PCMC. The possible in situ component in the tumor was assessed by the presence of a peripheral myoepithelial cell layer. Myoepithelial cell differentiation was confirmed with immunohistochemical stains for p63, CK 5/6, calponin, smooth muscle actin (SMA), HHF-35, and CD10. Estrogen and progesterone receptor (ER/PR), gross cystic disease fluid protein (GCDFP 15), CK7, CK20, and S-100 immunostains were also performed. Results: Histologically, multiple small monomorphic epithelial islands floating in multilocular pools of mucin characterized the tumor. Focally, epithelial islands were bordered by dermal connective tissue at the periphery of mucin pools. Secretory snouts were apparent in all cases providing evidence for apocrine differentiation. In 5 of the 7 cases, an in situ component was identified as epithelial islands being bounded by a myoepithelial layer, which was highlighted by p63, CK 5/6, calponin, SMA, and HHF-35. ER/PR and CK7 were positive in all the cases. GCDFP-15 and CD10 were focally positive in the tumor cells and myoepithelial cells, respectively. All 7 cases were negative for S-100 and CK 20. Conclusion: We conclude that an in situ component is frequently present in PCMC (5/7) and may help in distinguishing this entity from MMC, especially of breast origin. Furthermore, it may provide insight into the pathogenetic mechanism of mucinous carcinoma evolving from in situ carcinoma with luminal mucinous distention to cellular tumor with a little surrounding mucin.

AB - Background: Primary cutaneous mucinous carcinoma (PCMC) is a rare malignancy with probable apocrine differentiation. It is important to differentiate it from metastatic mucinous carcinoma (MMC), especially from the breast. The histologic and immunohistochemical features overlap between PCMC and breast mucinous carcinomas. In this study, we introduce the presence of myoepithelial component in PCMC as a new morphologic parameter to distinguish it from MMC from either breast or sites elsewhere in the body. Materials and Methods: We studied 7 cases of PCMC. The possible in situ component in the tumor was assessed by the presence of a peripheral myoepithelial cell layer. Myoepithelial cell differentiation was confirmed with immunohistochemical stains for p63, CK 5/6, calponin, smooth muscle actin (SMA), HHF-35, and CD10. Estrogen and progesterone receptor (ER/PR), gross cystic disease fluid protein (GCDFP 15), CK7, CK20, and S-100 immunostains were also performed. Results: Histologically, multiple small monomorphic epithelial islands floating in multilocular pools of mucin characterized the tumor. Focally, epithelial islands were bordered by dermal connective tissue at the periphery of mucin pools. Secretory snouts were apparent in all cases providing evidence for apocrine differentiation. In 5 of the 7 cases, an in situ component was identified as epithelial islands being bounded by a myoepithelial layer, which was highlighted by p63, CK 5/6, calponin, SMA, and HHF-35. ER/PR and CK7 were positive in all the cases. GCDFP-15 and CD10 were focally positive in the tumor cells and myoepithelial cells, respectively. All 7 cases were negative for S-100 and CK 20. Conclusion: We conclude that an in situ component is frequently present in PCMC (5/7) and may help in distinguishing this entity from MMC, especially of breast origin. Furthermore, it may provide insight into the pathogenetic mechanism of mucinous carcinoma evolving from in situ carcinoma with luminal mucinous distention to cellular tumor with a little surrounding mucin.

KW - Breast

KW - Metastatic carcinoma

KW - Mucinous carcinoma

KW - Myoepithelium

KW - Skin

UR - http://www.scopus.com/inward/record.url?scp=4644244083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644244083&partnerID=8YFLogxK

U2 - 10.1097/00000372-200410000-00001

DO - 10.1097/00000372-200410000-00001

M3 - Article

C2 - 15365364

AN - SCOPUS:4644244083

VL - 26

SP - 353

EP - 358

JO - American Journal of Dermatopathology

JF - American Journal of Dermatopathology

SN - 0193-1091

IS - 5

ER -